TickerFacts.

Jaguar Health, Inc. (JAGX): Revenue

Annual figures by period end, from SEC filings.

$11.51M
Year ended 2025-12-31
$27.82M
Trailing 12 months to 2026-06-30
-1.3%
3-year compound annual growth
+4.2%
5-year compound annual growth
+46.2%
10-year compound annual growth
$11.96M2014-12-31: $02015-12-31: $258.4K2016-12-31: $141.5K2017-12-31: $4.36M2018-12-31: $4.42M2019-12-31: $5.78M2020-12-31: $9.38M2021-12-31: $4.33M2022-12-31: $11.96M2023-12-31: $9.76M2024-12-31: $11.69M2025-12-31: $11.51M$11.51M
2014-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$11.51M-1.5%2026-04-07, From 2025-01-01
2024-12-31$11.69M+19.8%2026-04-07, From 2024-01-01
2023-12-31$9.76M-18.4%2025-03-31, From 2023-01-01
2022-12-31$11.96M+175.8%2023-03-24, From 2022-01-01
2021-12-31$4.33M-53.8%2023-03-24, From 2021-01-01
2020-12-31$9.38M+62.5%2021-03-31, From 2020-01-01
2019-12-31$5.78M+30.8%2021-03-31, From 2019-01-01
2018-12-31$4.42M+1.3%2020-04-03, From 2018-01-01
2017-12-31$4.36Mn/m2019-04-10, From 2017-01-01
2016-12-31$141.5K-45.2%2018-04-09, From 2016-01-01
2015-12-31$258.4Kn/a2017-02-15, From 2015-01-01
2014-12-31$0n/a2016-03-29, From 2014-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Jaguar Health, Inc. (JAGX)2025-12-31$11.51M-1.5%
Prelude Therapeutics Inc (PRLD)2025-12-31$12.14M+73.4%
Crescent Biopharma, Inc. (CBIO)2025-12-31$10.84Mn/a
Emmaus Life Sciences, Inc. (EMMA)2025-12-31$12.45M-25.2%
Evommune, Inc. (EVMN)2025-12-31$13.00M+85.7%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.11M+29.8%
Janux Therapeutics, Inc. (JANX)2025-12-31$10.00M-5.6%
Zenas BioPharma, Inc. (ZBIO)2025-12-31$10.00M+100.0%
Precigen, Inc. (PGEN)2025-12-31$9.68M+146.7%

Compare JAGX, PRLD, CBIO, EMMA side by side · Screen every company in Pharmaceutical Preparations ↗